Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 5533-5544 of 8180

Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration

PR Newswire associated0

Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure

Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl

Business Wire logo

Airway Therapeutics Wins 2024 ATS Whitsett Award for Abstract of Positive Phase 1b Results of Zelpultide Alfa in Preterm Neonates at Risk of Bronchopulmonary Dysplasia

The Oral Health Foundation launches oral health manifesto

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

Business Wire logo

Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa

PR Newswire associated0

Wingderm® Shines at IMCAS Asia 2024 with the Innovative Aesthetic Solutions

PR Newswire associated0

Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares

GlobeNewswire associated0

KFSHRC Successfully Produces the First Therapeutic T-Cells in the Kingdom

Business Wire logo

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia

  • Prev Page
  • 1
  • 2
  • …
  • 461
  • 462
  • 463
  • …
  • 681
  • 682
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us